An Overdiagnosis Epidemic Is Harming Patients’ Mental Health
Diagnosing patients when there aren’t effective treatments to give them can make their symptoms worse, argues neurologist Suzanne O’Sullivan.
A Lethal Mystery Illness Is Spreading in Congo. USAID Cuts Have Slowed the Response
Gutting USAID is already having a devastating impact around the world. In the Democratic Republic of Congo, teams that would normally be racing to identify a fatal sickness are gone.
Texas Official Warns Against ‘Measles Parties’ Amid Growing Outbreak
At least 146 measles cases have been identified in West Texas so far, including 20 hospitalizations and one death.
The US May Start Vaccinating Chickens Against Bird Flu
With egg prices soaring, the US is considering vaccinating laying chickens, which have been hit particularly hard by the avian influenza outbreak.
USAID Was Promised Emergency Waivers for Ebola and AIDS. They’re Not Working
Elon Musk claims he mistakenly fired Ebola prevention workers, then quickly fixed the error. But Ebola programs are still in tatters, along with other livesaving efforts like AIDS treatments for children.
A Deadly Unidentified Disease Has Emerged in the DRC
More than 50 people have died in the Democratic Republic of the Congo, most within 48 hours of the onset of symptoms. Initial analysis suggests neither Ebola nor Marburg is the cause.
DOGE Is Inside the National Institutes of Health’s Finance System
At least three people linked to Elon Musk’s DOGE task force have access to NIH systems that control budgets, procurement, and more, according to records and internal documents viewed by WIRED.
Nearly 100 Measles Cases Have Been Reported in Texas
The virus has spread in areas with low vaccination rates, and most of those affected are minors.
This New Drug Could Help End the HIV Epidemic—but US Funding Cuts Are Killing Its Rollout
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under threat.
The Ozempic Shortage Is Over
The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.